Roche Diagnostics supplies KAPA HYPEREXPLORE MAX 3MB T3 to BWC
- Birmingham Women's and Children's NHS Foundation Trust
- West Midlands
- Below threshold - without competition
- 6 May 2026 to 5 May 2027
Birmingham Women's and Children's NHS Foundation Trust is buying KAPA HYPEREXPLORE MAX 3MB T3 from Roche Diagnostics.
The product is a target enrichment panel for genomic sequencing, sold as a 96-reaction kit. It is a proprietary laboratory consumable for the trust's clinical diagnostic work.
The trust awarded the £20,530 contract directly, without a competition. It runs from May 2026 to May 2027.
Contract ends May 2027
- What
- Genomic sequencing platforms and consumables
- Supplier
- Roche Diagnostics
- Value
- £20,530
- How it was bought
- Below threshold - without competition
- Dates and next
- May 2026 to May 2027